www.cambridgecognition.com
Open in
urlscan Pro
62.182.18.140
Public Scan
Submitted URL: http://www.cambridgecognition.com/
Effective URL: https://www.cambridgecognition.com/
Submission: On August 22 via manual from IN — Scanned from GB
Effective URL: https://www.cambridgecognition.com/
Submission: On August 22 via manual from IN — Scanned from GB
Form analysis
1 forms found in the DOMPOST https://www.cambridgecognition.com/
<form method="post" action="https://www.cambridgecognition.com/">
<div class="hiddenFields">
<input type="hidden" name="params" value="eyJyZXN1bHRfcGFnZSI6InNlYXJjaCJ9">
<input type="hidden" name="ACT" value="104">
<input type="hidden" name="site_id" value="1">
<input type="hidden" name="csrf_token" value="9cc63b6476cfb6820e420c66863337abf91ca37b">
</div>
<div class="input">
<input type="search" name="keywords" id="keywords" maxlength="100" placeholder="Search keywords">
</div>
<div class="submit">
<input type="submit" name="Submit" id="Submit" value="Search" class="submitButton">
</div>
</form>
Text Content
By using the Cambridge Cognition website, without changing your settings, you agree to our use of cookies to enhance your browsing experience.x MENU * What we do ► * Overview * Improving clinical trial outcomes * Enabling real world digital health * Gold standard cognitive research * Products ► * Overview * Drug Development * Cognitive research * Healthcare Technology * NeuroVocalix * Services ► * Overview * Neuroscience consultancy * Study design * Data analysis * Study management * Data management * Reports & interpretation * Technical consultancy * CANTAB ► * Overview * Technology * Cognitive Tests * Test Batteries * Why choose CANTAB? * FAQs * Community ► * Overview * Bibliography * Funding Support * Videos * Resources * Licenses & Renewals * Ask a question * Webinars * Posters * Publications * About Us ► * Overview * Careers * Quality * News * Blog * Events * Charity of the Year * Investors ► * Overview * Shares * Shareholders * Announcements * Reports & Accounts * Board of Directors * Company information * Corporate Governance * Registrar * Investor alerts * contact * * * * Search Login Search Login * What we do * Overview * Improving clinical trial outcomes * Enabling real world digital health * Gold standard cognitive research * Products * Overview * Drug Development * Cognitive research * Healthcare Technology * NeuroVocalix * Services * Overview * Neuroscience consultancy * Study design * Data analysis * Study management * Data management * Reports & interpretation * Technical consultancy * CANTAB * Overview * Technology * Cognitive Tests * Test Batteries * Why choose CANTAB? * FAQs * Community * Overview * Bibliography * Funding Support * Videos * Resources * Licenses & Renewals * Ask a question * Webinars * Posters * Publications * About Us * Overview * Careers * Quality * News * Blog * Events * Charity of the Year * Investors * Overview * Shares * Shareholders * Announcements * Reports & Accounts * Board of Directors * Company information * Corporate Governance * Registrar * Investor alerts * contact * * * * Neuroscience technology for better brain health discover more Validated solutions to optimise clinical trial outcomes discover more Conduct virtual clinical trials and patient-centric research discover more Automated administration of verbal cognitive assessments discover more PrevNext 1 2 3 4 Cambridge Cognition is a leading neuroscience technology company optimising the assessment of cognition for better brain health research with scientifically validated digital health solutions. CLINICAL TRIAL OUTCOME ASSESSMENTS Optimise patient selection and demonstrate treatment outcomes REAL WORLD DIGITAL HEALTH SOLUTIONS Conduct patient-centric virtual clinical trials and identify digital biomarkers GOLD STANDARD COGNITIVE RESEARCH Assess all areas of cognition with the world's most sensitive cognitive tests CANTAB CONNECT ECOA The world's leading digital cognitive assessment and eCOA platform. CANTAB sensitively and objectively measures cognitive function, quantifies levels of performance and impairment, and demonstrates the effectiveness of interventions in brain health. The cloud technology enables efficient, non-invasive means of assaying brain function and participant outcomes, improving clinical trials and accelerating decision-making. The world’s most validated digital cognitive assessment platform Secure eCOA system trusted in over 2,000 clinical studies Regulatory accepted and compliant with 21 CFR Part 11, GCP and HIPAA standards Online and offline testing capability works with or without internet connection Real-time secure cloud data access links global study sites Remote web-based testing modes enable BYOD assessment of participants at home Easy to administer with automated test delivery requires minimal rater training and removes human error Electronic data capture and automatic scoring and reporting enhances data quality PrevNext 1 2 3 4 5 6 7 8 discover more DRUG DEVELOPMENT MAXIMISE THE CHANCES OF SUCCESS IN CLINICAL TRIALS Industry-leading and regulatory-accepted digital products to optimise and accelerate safe, effective and efficient drug development. * Enrich clinical trial recruitment * Develop new treatments * Improve patient outcomes * Enhance R&D efficiency discover more DIGITAL HEALTH ASSESS AND IMPROVE BRAIN HEALTH AND MENTAL WELLBEING Medical devices and digital health technology to collect real world outcomes data, identify patients, detect impairments early, and track wellbeing over time. * Alzheimer's screening * Cognitive health assessments * Mental health at work discover more COGNITIVE RESEARCH THE GOLD STANDARD IN COGNITIVE ASSESSMENT The world's most recognised digital cognitive testing platform for all areas of brain research providing sensitive assessment of cognitive domains in-person and online. * CANTAB cognitive assessments * Training and support * Neurocience consultancy discover more * * * * Tel: +44 (0)1223 810 700 Email: info@camcog.com * Home * What we do * Services * Products * Technology * Resources * About * Contact * Careers * Privacy * Terms of use * Investors Copyright © 2022 Cambridge Cognition Ltd All rights reserved Registered in England and Wales Company no. 4338746